Perspectives on interferon-alpha in the treatment of polycythemia vera and related myeloproliferative neoplasms: minimal residual disease and cure?

Overview of attention for article published in Seminars in Immunopathology, September 2018

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (68th percentile)
Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

twitter: 6 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 75 Dimensions

Readers on

mendeley: 89 Mendeley

Summary X Facebook Dimensions citations

So far, Altmetric has seen 1 public wall post.

MPN, 15 Sep 2018

The first clinical trials of the safety and efficacy of interferon-alpha2 (IFN-alpha2) were performed about 30 years ago. Since…

This page shows the most recent Facebook posts that mention this research output.

Click here to find out how to access more activity.